340B Court Decision Threatens To Expand Patient Eligibility; Can Pharmacy Restrictions Counter Program Growth?

Court ruling in litigation brought against the US government by Genesis Healthcare may elicit competing reactions among stakeholders but is expected to stir up the 340B market.

Stakeholders Increasingly Taking Matters Into Their Own Hands • Source: Shutterstock

More from Market Access

More from Pink Sheet